Investigating stage-specific metabolic alterations in colorectal cancer through urine metabolomics
- 22 October 2025
- journal article
- research article
- Published by Springer Nature in Metabolomics
- Vol. 21 (6) , 1-13
Abstract
Background Colorectal cancer (CRC) ranks as the third most prevalent malignancy globally, presenting a formidable early diagnostic challenge. An effective biomarker with high sensitivity and specificity can help diagnose CRC and improve the chances of successful treatment. Methods 100 healthy controls and 95 CRC patients (25 Stage 0/I, 30 stage II and 40 stage III based on Clinical stages) were recruited. Subsequently, 195 urine samples were subjected to UPLC-MS analysis. Comparative analysis was employed to elucidate noteworthy metabolic variances, and pathway analysis was conducted to unveil perturbed metabolic functions. Ultimately, metabolic panels for CRC diagnosis were constructed. Result A total of 82 metabolites exhibited statistical significance between CRC patients and healthy controls. Moreover, pathway analysis revealed that they were associated with Steroid hormone biosynthesis, Nitrogen metabolism, and D-Glutamine and D-glutamate metabolism. A composite panel consisting of Retinol, L-β-aspartyl-L-glycine, and 21-Deoxycortisol showed AUCs of 0.933/0.93 in the discovery/validation group. The panel also showed commendable efficacy across different CRC stages when these stages were compared with the healthy group,with an AUC of 0.918 for stages 0/I, 0.862 for stage II, and 0.845 for stage III. Conclusions Urine metabolome could distinguish CRC from healthy controls and reflect the changes in different stages of CRC. Potential biomarkers might be developed by targeted metabolomic analysis.Keywords
Funding Information
- National Natural Science Foundation of China (No.82170524,31901039 and 82073327)
- Beijing Medical Research (No.2018-7)
- CAMS Innovation Fund for Medical Sciences (2021-I2M-1-016,2022-I2M-1-020 and 2021-I2M-1-066)
This publication has 67 references indexed in Scilit:
- Serum nuclear magnetic resonance metabolomics analysis of human metastatic colorectal cancer: Biomarkers and pathway analysisNMR in Biomedicine, 2023
- Optimal Strategies for Colorectal Cancer ScreeningCurrent Treatment Options in Oncology, 2022
- GLS1 depletion inhibited colorectal cancer proliferation and migration via redox/Nrf2/autophagy-dependent pathwayArchives of Biochemistry and Biophysics, 2021
- Diagnosis and Treatment of Metastatic Colorectal CancerJAMA, 2021
- Osmolality-based normalization enhances statistical discrimination of untargeted metabolomic urine analysis: results from a comparative studyMetabolomics, 2021
- Recurrence‐associated gene signature optimizes recurrence‐free survival prediction of colorectal cancerMolecular Oncology, 2017
- Dietary supplement use and colorectal cancer risk: A systematic review and meta‐analyses of prospective cohort studiesInternational Journal of Cancer, 2014
- Serum steroid profiling for Congenital Adrenal Hyperplasia using liquid chromatography–tandem mass spectrometryClinica Chimica Acta, 2010
- Ultra-High Performance Liquid Chromatography–Mass Spectrometry for the Metabolomic Analysis of Urine in Colorectal CancerDigestive Diseases and Sciences, 2009
- Measurement of urinary concentration: a critical appraisal of methodologiesPediatric Nephrology, 2001